Literature DB >> 11871514

Mandatory screening and treatment of immigrants for latent tuberculosis in the USA: just restraint?

R Coker1, K L van Weezenbeek.   

Abstract

A report by the Institute of Medicine, Ending Neglect, and sponsored by the US Centers for Disease Control and Prevention, makes recommendations for achieving elimination of tuberculosis in the USA. Among them is the recommendation that a mandatory screening programme be introduced for latent tuberculosis infection in immigrants from high prevalence countries, and that the provision of a permanent residence card (green card) be linked to the completion of an approved course of preventive treatment. We examine the evidence put forward to support this proposal and assess whether such a mandatory programme for preventive treatment of individuals, who do not pose an immediate risk but could pose a risk in the future, meets internationally recognised standards for coercive public-health measures. We conclude from our analysis that there is reason to question (i) the risk analysis, (ii) the estimates of effectiveness of such a policy, (iii) the cost calculations, and (iv) the operational consequences put forward in the report. Moreover, we show that international standards for mandatory screening and treatment are not met.

Entities:  

Mesh:

Year:  2001        PMID: 11871514     DOI: 10.1016/s1473-3099(01)00122-0

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  5 in total

1.  Immigration and a sneak resurgence of tuberculosis: déjà vu.

Authors:  Zakari Y Aliyu
Journal:  Wien Klin Wochenschr       Date:  2003-09-30       Impact factor: 1.704

Review 2.  Effectiveness and cost effectiveness of screening immigrants schemes for tuberculosis (TB) on arrival from high TB endemic countries to low TB prevalent countries.

Authors:  A F N S Sanneh; A M Al-Shareef
Journal:  Afr Health Sci       Date:  2014-09       Impact factor: 0.927

3.  Role of the QuantiFERON(R)-TB Gold In-Tube assay in screening new immigrants for tuberculosis infection.

Authors:  Christiaan Mulder; Henk van Deutekom; Erik M Huisman; Sophie Toumanian; Ben F P J Koster; Wieneke Meijer-Veldman; Joke H van Loenhout-Rooyackers; Milo Appel; Sandra M Arend; Martien W Borgdorff; Frank van Leth
Journal:  Eur Respir J       Date:  2012-04-10       Impact factor: 16.671

4.  Cost-effectiveness of Latent Tuberculosis Infection Screening before Immigration to Low-Incidence Countries.

Authors:  Jonathon R Campbell; James C Johnston; Victoria J Cook; Mohsen Sadatsafavi; R Kevin Elwood; Fawziah Marra
Journal:  Emerg Infect Dis       Date:  2019-04       Impact factor: 6.883

5.  High incidence of pulmonary tuberculosis persists a decade after immigration, The Netherlands.

Authors:  Annelies M Vos; Abraham Meima; Suzanne Verver; Caspar W N Looman; Vivian Bos; Martien W Borgdorff; J Dik F Habbema
Journal:  Emerg Infect Dis       Date:  2004-04       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.